癌症（英文版）Issue(4)：149-160,12.DOI:10.1186/s40880-015-0007-9
Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer:EGFR and beyond
Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer:EGFR and beyond
Christopher Delaney 1Samuel Frank 1R Stephanie Huang2
作者信息
- 1. Biological Sciences Division, University of Chicago, Chicago, IL 60637, USA.
- 2. Department of Medicine, University of Chicago, 900 E 57th street, KCBD room 7148, Chicago, IL 60637, USA
- 折叠
摘要
关键词
Pharmacogenomics/Non-small cell lung cancer (NSCLC)/Epidermal growth factor receptor (EGFR)/Cetuximab/ErlotinibKey words
Pharmacogenomics/Non-small cell lung cancer (NSCLC)/Epidermal growth factor receptor (EGFR)/Cetuximab/Erlotinib引用本文复制引用
Christopher Delaney,Samuel Frank,R Stephanie Huang..Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer:EGFR and beyond[J].癌症（英文版）,2015,(4):149-160,12.
